Pharmacological, Hematological, and Physiological Effects of a New Thromboxane Synthetase Inhibitor (CGS-13080) During Cardiopulmonary Bypass in Dogs
Open Access
- 1 December 1986
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 42 (6) , 690-696
- https://doi.org/10.1016/s0003-4975(10)64611-5
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1985
- Prostacyclin in aortocoronary bypass surgery: A double-blind, placebo-controlled studyThrombosis Research, 1983
- Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of β-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1α and heparinThrombosis Research, 1983
- Neuropsychological dysfunction following elective cardiac operationThe Journal of Thoracic and Cardiovascular Surgery, 1982
- Neuropsychological dysfunction following elective cardiac operationThe Journal of Thoracic and Cardiovascular Surgery, 1982
- INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATIONThe Lancet, 1981
- Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial CellsJournal of Clinical Investigation, 1980
- Platelet Dysfunction Associated with Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1978
- Maximum Likelihood Approaches to Variance Component Estimation and to Related ProblemsJournal of the American Statistical Association, 1977
- Indium-111 labeled platelets: Studies on preparation and evaluation of in vitro and in vivo functionsThrombosis Research, 1976